Global Oxygenators Market Expected to Reach USD 419.5 Million by 2033 - IMARC Group

Global Oxygenators Market Statistics, Outlook and Regional Analysis 2025-2033

The global oxygenators market size was valued at USD 271.9 Million in 2024, and it is expected to reach USD 419.5 Million by 2033, exhibiting a growth rate (CAGR) of 4.94% from 2025 to 2033.

There are several important global trends in the oxygenators market as a result of the advancements in medical technology, increasing healthcare needs and the rising emphasis on improved patient outcomes. The emergence of advanced oxygenators which feature real-time monitoring systems and subsequently offers precision in oxygen supply management for surgical procedures is a major trend. Such innovations are a response to the increasing demand for more efficient and effective medical devices mainly in critical care and cardiopulmonary bypass surgery applications. Another novel and evolutionary trend is a move toward portable and compact oxygenators that are designed to offer greater convenience to patients and healthcare providers. Such devices are becoming commonplace in outpatient care settings with respect to patients with chronic respiratory diseases requiring long-term oxygen supplementation. Apart from this, another temporal change in the oxygenators market is the trend toward greener, more sustainable products. This trend has made manufacturers consider materials and technologies that have a lower impact on the environment. There is also an increased attention toward patient-centered designs of oxygenators, with extra comfortable and safer designs being made in order to minimize the incidence of complications associated with their usage.

The global oxygenators market is experiencing robust growth, driven by the rising prevalence of respiratory diseases, such as chronic obstructive pulmonary disease (COPD), asthma, and pneumonia, which are leading to an increased demand for oxygen therapy. According to the World Health Organization (WHO), COPD is the fourth leading cause of death worldwide, which caused 3.5 million deaths in 2021, which is approximately 5% of all global deaths. This further supports and necessitates the use of oxygenators worldwide. The aging population is also contributing to the market growth, as older individuals are more prone to respiratory conditions and require oxygen support for prolonged periods. According to the IMARC group, the global respiratory care devices market size was valued at USD 23.5 Billion in 2024 and is further expected to reach USD 43.5 Billion by 2033. Additionally, the growing number of cardiovascular diseases, including heart failure and arrhythmias, is fueling the need for oxygenators in surgeries like cardiopulmonary bypass. Another significant driver is the ongoing advancements in medical technology, particularly in the development of more efficient, safer, and compact oxygenators that offer improved patient outcomes. These innovations are encouraging hospitals and healthcare facilities to adopt more advanced equipment.

Global Oxygenators Market Statistics, By Region

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia-Pacific (China, India, Japan, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share on account of advanced healthcare infrastructure, high disease prevalence, technological innovation, and strong healthcare spending.

North America Oxygenators Market Trends:

North America is poised to witness huge increase in its oxygenators market owing to the growing incidence of cardiovascular disease cases and respiratory ailments requiring more medical interventions among an ageing population. As per US Centers for Disease Control and Prevention, one person dies every 33 seconds from cardiovascular disease in US. Oxygenators are used during cardiopulmonary bypass procedures and high-risk surgeries as well as in extracorporeal membrane oxygenation (ECMO) especially for those patients suffering from severe conditions of the heart or lungs. The change in equipment use has also been attributed to advancing technologies that are developing smaller, more effective, and simpler-to-use oxygenators. Improvements in health infrastructure as well as increased attention given to emergency care are contributing to growth in the market. The support of medical professionals along with the bulk of investments made into the medical research sector contribute to expansion strides of North America. Government regulations and reimbursement policies are equally important drivers in shaping the market dynamics as they have impacted on how easily these oxygenation therapies could be availed.

Asia-Pacific Oxygenators Market Trends:

Increasing incidences of cardiovascular diseases and respiratory conditions, combined with an aging population, have led to rapid growth in healthcare needs across the Asia Pacific region, thus leading to the booming market for oxygenators. The trend continues to develop further in emerging markets such as China, India, and the other Southeast Asian countries with the advancement of their healthcare infrastructure, thus increasing the demand for advanced medical devices, including oxygenators. Oxygenators play a major role in complex surgeries, cardiopulmonary bypass procedures, and extracorporeal membrane oxygenation (ECMO) treatment, which have become common for patients with severe conditions of the heart and lung. The market is also driven by improved technology, through which more efficient and compact oxygenators are produced that can be more easily and affordably accessed. Investments by the government in the area of health, in addition to improved awareness about advanced medical treatments, have also contributed to growth in the market in the region.

Europe Oxygenators Market Trends:

The Europe oxygenators market is on a stable growth trajectory underpinned by an advanced health care system and a considerable demand for life-saving medical devices in the region. The prevalence of cardiovascular diseases and respiratory disorders in Europe has led to an increase in the adoption of oxygenators in the critical care environment. The market still boasts well-established health care infrastructures, including some of the most advanced oxygenation technologies in critical cardiopulmonary bypass, ECMO, and respiratory support facilities used in hospitals in Germany, the UK, and France. Regulatory support such as policies aimed at improvement in healthcare quality and safety of medical devices also helps in market growth. Moreover, the growing number of surgical procedures, especially heart transplants and bypass operations, will also add to the increasing demand for the oxygenators market in the region.

Latin America Oxygenators Market Trends:

The Latin America segment of oxygenators market is growing due to rising demand for modern medical technologies in critical care. Countries like Brazil, Mexico, and Argentina are seeing rising incidences of cardiovascular diseases and respiratory disorders; this is raising the demand for oxygenators in procedures like cardiopulmonary bypass and ECMO. The entire health system of the region is undergoing significant changes, with important investments made in new medical equipment and facilities especially in the major urban centers. In addition, increasing awareness regarding advanced treatment options and improved access to health services in both public and private foot contributes to the market growth.

Middle East and Africa Oxygenators Market Trends:

The oxygenators market in the Middle East and Africa (MEA) is on the rise due to various healthcare investments in the countries of the Gulf Cooperation Council (GCC) such as Saudi Arabia, the UAE, and Qatar. This is because these countries are upgrading their facilities and expanding critical care capabilities to cope with the increasing number and trends of cardiac diseases, respiratory disorders, and an elderly population. The growing number of lifestyle diseases, such as diabetes and hypertension, which need oxygenation support during surgeries like heart surgeries and ECMO, has also expanded the market. Other than this, there have been significant government initiatives in the MEA region that are poised to drive the adoption of advanced technologies in medicine and boost the overall quality of healthcare infrastructure in the region.

Top Companies Leading in the Oxygenators Industry

Some of the leading oxygenators market companies include Braile Biomédica, Eurosets S.r.l., Getinge AB, Livanova Plc, Chalice Medical Ltd, Medtronic plc, MicroPort, Nipro Corporation, Senko Medical Instrument Mfg. Co. Ltd., Xenios AG (Fresenius Medical Care AG & Co. KGaA) and Terumo Medical Corporation (Terumo Corporation) among many others.

• In September 2024, Medtronic plc introduced its innovative extracorporeal membrane oxygenation (ECMO) system, VitalFlow. This system utilizes an external pump and oxygenator to perform the functions of the heart and lungs, providing life-saving support to critically ill patients and helping to restore their health.

Global Oxygenators Market Segmentation Coverage

• On the basis of the type, the market has been categorized into membrane oxygenator and bubble oxygenator, wherein membrane oxygenator represents the leading segment. A membrane oxygenator is a critical device used in medical procedures like cardiopulmonary bypass and extracorporeal membrane oxygenation (ECMO). It works by transferring oxygen into the blood and removing carbon dioxide through a semi-permeable membrane. Blood flows over the membrane, while oxygen is introduced and CO2 is diffused out. This mimics lung function, supporting patients with severe respiratory or cardiac issues.
• Based on the age group, the market is classified into neonates, pediatric, and adults. Neonates are infants less than 28 days old and often require specialized oxygenation support due to underdeveloped lungs and respiratory conditions. These delicate newborns require gentle gas exchange with low blood flow resistances to achieve the best oxygenation and also to avoid damage on tender lung tissues. Pediatric patients aged 28 days until they reach teenage years might require oxygenators either during surgeries or in the critical care unit, especially those facing respiratory or heart failure. Pediatric oxygenators come in small sizes created to fit the bodies of children. These should be specifically according to the metabolic needs which have to be satisfied by specific tailored blood flow rates and gas exchange. While in the past, adults have only been able to have oxygenators during complex surgery or in a situation of severe respiratory failure, they may also be required during cardiopulmonary bypass or ECMO procedures. Oxygenators for adults are made to cope with larger volumes of blood and increased flow rates, allowing efficient oxygenation and elimination of carbon dioxide from the transpired gases. These devices are crucial in supporting patients having heart surgery, undergoing organ transplantation or people suffering from severe lung diseases.
• On the basis of the application, the market has been divided into respiratory, cardiac, extracorporeal cardiopulmonary, and resuscitation (ECPR), amongst which respiratory leads the market segment. Oxygenators are vital in the management of patients suffering from diverse lung afflictions and in the case of acute respiratory distress syndrome (ARDS), pneumonia, or chronic obstructive pulmonary disease (COPD). These devices temporarily take over oxygenation as well as the removal of carbon dioxide from the lungs when their function is no longer efficient. Oxygenators are usually supplemented with mechanical ventilation or ECMO for patient gas exchange, especially in patients with considerable loss of respiratory function. Primarily, they are lifesaving in intensive care units and allow time for treatment or recovery of any pathology in the lungs.